Corporate Announcement
Security Code : 507789    Company : JAGSNPHARM    
 
Jagsonpal Pharmaceuticals - Outcome of AGM 
  Exchange Disseminated Time     
Jagsonpal Pharmaceuticals Ltd has informed BSE that the members at the 29th Annual General Meeting (AGM) of the Company held on September 29, 2008, inter alia, have accorded the following:

1. Adopted the Audited Balance Sheet as at March 31, 2008, and the Profit and loss account for the year ended on that date along with the reports of the Auditors and Directors thereon.

2. Declared 2% dividend on the Equity Shares.

3. Re-appointed Dr. S K Goyal as Director whose period of office is liable to determination by retirement of Directors by rotation.

4. Appointed P P Thukral & Company, Chartered Accountants as Auditor to hold office till the conclusion of next Annual General Meeting.

5. Approved Special Resolution for increase in remuneration of Chairman.

6. Approved Special Resolution for increase in remuneration of Managing Director.
 

Disclaimer

Back To Announcements